Fri, Aug 22, 2014, 5:53 AM EDT - U.S. Markets open in 3 hrs 37 mins

Recent

% | $
Quotes you view appear here for quick access.

Biogen Idec Inc. Message Board

  • janiecebarraz janiecebarraz Jul 20, 2011 4:55 PM Flag

    Biogen, Bayer MS Drugs Aren’t Cost Effective in U.S., Study Says

    I love how the article "Biogen, Bayer MS Drugs Aren’t Cost Effective in U.S., Study Says" portrays BIIB. Sell BIIB, then read it here. http://top-wallstreet-picks-online.info/BIIB

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Yes, Biogen has the FDA in their pocket.

      Declare their MS products "orphan drugs", charge super high prices unrelated to their cost of development or production and rape the USA consumer. Insurance companies go along with this since they get a piece of the action, too. The other MS drugs all have different production processes but they all charge the consumer about the same. Absolutely NO price competition in this rigged market place.

      Any data showing MS drugs have any effect after 5 or 10 years? I know it works in the early stages, but there is no PUBLISHED data about long term benefits.

 
BIIB
338.65-3.93(-1.15%)Aug 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.